Prior Authorization AI: What CMS-0062-P Means for Coders

Prior Authorization AI: What CMS-0062-P Means for Medical Coders

Healthcare providers spend an average of 13 hours per week and $34,000 per year managing prior authorization requests — and those numbers are about to change. On April 14, 2026, CMS published proposed rule CMS-0062-P in the Federal Register, extending electronic prior authorization requirements from non-drug services to drug coverage for the first time. Public comments are due June 15, 2026.

For revenue cycle teams, the implication is straightforward: how prior authorizations are requested, processed, and denied is getting more automated — and more auditable. For medical coders specifically, that shift creates both new risk and a concrete opportunity to reduce denials before they happen.

What CMS-0062-P Actually Requires

The 2024 interoperability final rule (CMS-0057-F) required payers to implement FHIR-based APIs for prior authorization of non-drug services. CMS-0062-P extends those same standards to drug prior authorizations across Medicare Advantage, Medicaid, CHIP, and qualified health plans on the federal exchange.

The proposed rule's key requirements include shorter decision timeframes — 24 hours for Medicaid and CHIP drug PA requests, and 72 hours standard with 24 hours expedited for qualified health plans. Payers must provide a specific reason for every denied PA decision, regardless of the channel used to communicate it. FHIR is proposed as the HIPAA transaction standard for drug PA. And payers will be required to report their API endpoints and usage metrics directly to CMS.

Drug PA compliance is proposed for October 1, 2027. The comment period closes June 15, 2026 — organizations with specific concerns about implementation timelines still have time to weigh in at the Federal Register docket.

Why Medical Coders Are Caught in the Middle

Prior authorization isn't just a billing problem — it starts with the code. When a coder assigns an ICD-10-CM diagnosis code or selects a CPT procedure code, that combination often determines whether a PA is required, and whether the clinical documentation can support the request.

Payers' PA criteria are diagnosis-and-procedure-specific. A hospitalist who documents "unspecified pneumonia" (J18.9) may not trigger the same PA pathway as one who documents "community-acquired pneumonia due to Streptococcus pneumoniae" (J13) — but the clinical facts may support the more specific code, and that code may carry entirely different PA requirements. Under CMS-0062-P's specific denial reason mandate, coders will finally have clear insight into exactly why PA decisions fail. But that data only closes the loop if organizations route it back to coding teams promptly.

Separately, CMS's WISeR (Wasteful and Inappropriate Service Reduction) program — running January 1, 2026 through December 31, 2031 in six states (Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington) — has introduced prior authorization requirements in original Medicare for select outpatient services. For coders in those states, the PA burden is already higher this year than it was in 2025.

The Documentation-to-Authorization Pipeline

In most hospitals and physician groups, the coding-to-PA workflow moves in one direction: a coder assigns codes from documentation, a biller triggers a PA request using those codes, and the payer approves or denies based on coverage criteria. When the denial comes back, it typically cites a criterion the original clinical documentation might have supported — if the code had been more specific, or if the encounter note had included one more sentence of clinical reasoning.

The specific denial reasons mandated by CMS-0062-P will make that gap visible in a way it hasn't been historically. Coders will be able to see which diagnosis-procedure-drug combinations are generating denials, and why. That's a feedback loop that currently takes weeks to close; with electronic PA and structured denial data, it can close in hours.

How Agentic AI Closes the Gap

This is where agentic AI moves from theoretical to operational.

Pre-Screening: Catching PA Requirements Before Claims Go Out

Agentic AI systems can cross-reference assigned codes against payer-specific PA requirement databases in real time. When a coder finalizes a code set that triggers a PA requirement for a given payer, an AI agent flags it before the claim leaves the system — prompting the team to confirm the PA has been obtained or escalating to a PA coordinator. This eliminates the reactive cycle of submitting a claim, receiving a denial, appealing, and waiting.

Several vendor platforms announced or expanded these capabilities in early 2026. FinThrive unveiled its agentic AI-powered revenue cycle platform at HIMSS 2026 in March, citing more than 50 AI and automation use cases including PA pre-screening. Adonis, which raised $40 million in Series C funding in March 2026, is building AI agents specifically designed to detect PA vulnerabilities before claims are submitted. Waystar has extended its AltitudeAI platform to include PA monitoring agents as part of its move toward autonomous revenue cycle management.

Denial Intelligence: Turning Specific Reasons Into Root Cause Fixes

CMS-0062-P's requirement for specific denial reasons creates structured data that AI can analyze at volume. Instead of a generic "not medically necessary" reason, coding and billing teams will receive denial codes tied to specific clinical criteria. Agentic AI can aggregate those reasons across an organization's full book of business, identify patterns — for example, a particular diagnosis-drug combination at a specific payer generating denials at a high rate — and surface actionable recommendations to CDI specialists and coders.

That kind of root cause analysis takes human analysts weeks. AI running against structured denial data can do it nightly, producing daily or weekly reports that target the highest-impact documentation gaps first.

What Coding Teams Should Do Now

Organizations do not need to wait until October 2027 to start preparing. The structural changes CMS-0062-P will require from payers will create data flows that forward-thinking RCM teams can leverage today. Concrete steps include:

• Map your PA exposure. Identify which CPT and ICD-10-CM combinations most frequently trigger PA requirements across your top five payers, then prioritize those for AI-assisted pre-screening first.

• Close the denial feedback loop. Build a process to route denied PA reasons back to coding and CDI teams within 48 hours of receipt — not at next month's review meeting.

• Evaluate your tech stack. Ask your EHR and RCM vendors specifically whether they will support FHIR-based drug PA transactions under CMS-0062-P, and by what date.

• Document at maximum specificity. Use ICD-10-CM codes at the highest specificity your documentation supports. The difference between a specificity code and an unspecified code frequently determines both PA requirements and outcomes.

• Submit comments before June 15. Organizations with concerns about implementation timelines or technical standards can still shape this rule before it is finalized.

The Bottom Line

CMS-0062-P is a structural change that will touch every layer of the revenue cycle — from payer technology infrastructure to coder documentation habits to biller submission workflows. Organizations that prepare now will spend less time on avoidable denials and administrative rework when the mandate takes effect in 2027.

Agentic AI is the practical tool that makes early preparation scalable: pre-screening PA requirements at the point of code assignment, analyzing structured denial data at volume, and keeping CDI and coding teams informed before problems compound. Medikode's automated medical coding platform is built to close exactly this gap — connecting coding precision to prior authorization outcomes before the claim ever leaves your system.